Urine proteomics biomarkers in renal transplantation: An overview

Transplantation

Volumn 88, Issue SUPPL. 3, 2009, Pages

  Quintana, Luis F ^a,b   Bañon Maneus, Elisenda ^b   Solé Gonzalez, Amanda ^b   Campistol, Josep M ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute rejection; Chronic allograft dysfunction; Chronic antibodymediated rejection; Interstitial fibrosis; Proteomics; Urine biomarkers.

Indexed keywords

ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; BETA DEFENSIN 1; BIOLOGICAL MARKER; ENDOREPELLIN; PREALBUMIN; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; CHRONIC ALLOGRAFT NEPHROPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; URINE LEVEL;

CYSTITIS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS; URINARY TRACT INFECTIONS;

EID: 70349083398     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181af7cba     Document Type: Review

References (22)

1. Ideker T, Thorsson V, Ranish JA, et al. Integrated genomic and pro-teomic analyses of a systematically perturbed metabolic network. Science 2001; 292: 929.
2. US Renal data system. US Renal Data System: Excerpts from the USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2003; 42: s1.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
4. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235.
5. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999; 56: 783.
6. Gwinner W. Renal transplant rejection markers. World J Urol 2007; 25: 445.
7. Kuypers DRJ. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: Impact and effect. Transplantation 2008; 85: S25.
8. Clarke W, Silverman BC, Zhang Z, et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003; 237: 660.
9. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Neph-rol 2004; 15: 219.
10. O'Riordan E, Orlova TN, Mei JJ, et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004; 15: 3240.
11. Kiehntopf M, Siegmund R, Deufel T. Use of SELDI-TOF mass spec-trometry for identification of new biomarkers: Potential and limitations. Clin Chem Lab Med 2007; 45: 1435.
12. Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005; 5: 729.
13. O'Riordan E, Orlova TN, Podust VN, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant 2007; 7: 930.
14. Fliser D, Novak J, Thongboonkerd V, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 2007; 18: 1057.
15. Zurbig P, Renfrow MB, Schiffer E, et al. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 2006; 27: 2111.
16. Wittke S, Haubitz M, Walden M, et al. Detection of acute tubulointer-stitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant 2005; 5: 2479.
17. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
18. Beckingham IJ, Nicholson ML, Bell PR. Analysis of factors associated complications following renal transplant needle core biopsy. Br J Urol 1994; 73: 13.
19. Rush DN, Nickerson P, Jeffery JR, et al. Protocol biopsies in renal transplantation: Research tool or clinically useful? Curr Opin Nephrol Hypertens 1998; 6: 691.
20. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643.
21. O'Riordan E, Orlova TN, Mendelev N, et al. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl 2008; 2: 1025.
22. Quintana LF, Solé-Gonzalez A, Kalko SG, et al. Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 2009; 20: 428.